Cellebrite DI Ltd. (9W9)
Market Closed
17 Jul, 20:00
XSTU 
€
13. 51
-0.3
-2.2085%
€
- Market Cap
- P/E Ratio
- Div Yield
2,646 Volume
- Eps
€ 13.81
Previous Close Want to track 9W9 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cellebrite DI Ltd. (9W9) Statistics
Valuation metrics
Market Cap -
Enterprise value -101.79M
Trailing P/E (ttm) 36.97
Forward P/E -
PEG ratio 2.96
Price/Sales (ttm) -
Price/Book (mrq) 5.99
Enterprise Value/Revenue -0.21
Enterprise Value/EBITDA -0.99
Overview
Shares outstanding 248.58M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 180
Average volume (90 days) 66
Price summary
52-Week low 9.25
52-Week high 17.2
Beta -
50-Day moving average 11.51
200-Day moving average 13.65
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.84%
Operating margin 0.19%
Operational effectiveness
Return on assets 0.08%
Return on equity 0.16%
Income Statement
Revenue (ttm) 475.68M
Revenue per share (ttm) 1.97
Quarterly revenue growth (yoy) 0.02%
Gross profit (ttm) 400.5M
EBITDA 116.58M
Net income to common (ttm) 77.3M
Diluted EPS (ttm) 0.31
Quarterly earnings growth (yoy) 0.41%
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 22.67M
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 1.56%
Book value per share (mrq) 1.97
Cash Flow
Cash flow statement 163.74M
Levered free cash flow (LFCF) 77.81M
